Aims : We evaluated therapeutic outcomes of microwave coagulation therapy (MCT) for hepatocellular carcinoma (HCC).
Materials and Methods : Forty patients including 30 primary and 10 recurrent cases undergoing MCT at our institute between January 1995 and December 2000. In the 10 recurrent cases, hepatectomy, percutaneous ethanol injection therapy (PEIT) and transarterial infusion therapy (TAI) had been performed in 8, 1, and 1, respectively as the first therapeutic procedure. The average tumor size and number of tumors in 40 patients were 2.7cm and 1.6, respectively.
Results : The one-, three- and five-year cumulative survival rates were 84.7%, 45.3% and 32.6%, respectively. Good clinical results were obtained in recurrent cases with hepatectomy, liver damage A, tumors less than 3 cm in size, Stage I, well-differentiated tumors, and a percutaneous. Local recurrence occurred in 4 of 65 nodules and the local recurrent rate was 6.2%. Complications occurred in 21 patients (52.5%) including 5 with high fever above 38.5°C, 1 with ascites, and 1 with hyperbilirubinemia.
Conclusions : MCT appears to be effective in treating HCC tumors less than 3 cm in size.
View full abstract